Minneapolis-based Preventice announced this week that the FDA had cleared its remote monitoring device for patients with cardiac arrhythmias, the BodyGuardian Remote Monitoring System, with a 510(k) clearance. Preventice developed the system with its partner Mayo Clinic and licensed technology from Proteus Biomedical's partner Avery Dennison for the peel-and-stick sensor.
BodyGuardian is a small...
